Cybin (HELP) Short term Debt (2021)

Cybin (HELP) posted quarterly Short term Debt of $2.4 million for Q4 2021, up 730.83% on a QoQ basis from $288370.6 in Q3 2021.

Cybin (HELP) Short term Debt (2021) Analysis & Trends

Cybin (HELP) has reported Short term Debt for 1 consecutive years, with $2.4 million the latest figure, recorded in Q4 2021.

Quarterly Short term Debt changed N/A year-over-year to $2.4 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $2.4 million (changed N/A YoY) and the FY2021 annual result came in at $828319.0, changed N/A from the prior year.
Short term Debt improved to $2.4 million in Q4 2021 per HELP's latest filing, from $288370.6 in the prior quarter.
Over the last five years, Short term Debt for HELP reached as high as $2.4 million in Q4 2021 and fell as low as $288370.6 in Q3 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Cybin	28.04 Mn	28.04 Mn	-

Download Data